February 22, 2022 – Oxford, United Kingdom – The British Society of Pharmacology (BPS), the charitable organization whose mission is to promote and advance all disciplines of pharmacology in the discovery, development and use of medicines, and a world leader in research and education Wiley, today announced their renewed publishing partnership. Wiley will continue to publish major BPS journals, the British Journal of Pharmacology (BJP) and the British Newspaper clinical pharmacology (BJCP), from 2023 to 2029.
BPS CEO Rachel Lambert-Forsyth said, “Pharmacology makes a unique contribution to research to develop new drugs and improve the use of existing drugs for better patient outcomes. Our journals disseminate this world-class research in pharmacology and provide opportunities for our members to come together so they can collaborate, debate, publish, and ultimately make progress in priority research areas. Wiley supports us in this mission with their expertise in education and research and we are excited to continue our partnership.
First published in 1946, the British Journal of Pharmacology is the leading international journal of general pharmacology, publishing high-quality original research and authoritative reviews on all aspects of experimental pharmacology. BJP is committed to leading the field in open research, transparency, and scientific rigor, and hosts the highly regarded Concise guide to pharmacology. The magazine celebrated its 75and birthday in 2021.
First published in 1974, the British Journal of Clinical Pharmacology is a leading international journal of clinical pharmacology that bridges the gap between the medical profession, clinical research and the pharmaceutical industry by addressing all aspects of drug action in humans.
“As the world’s largest society publisher, we are delighted to continue our more than 25-year partnership with the British Pharmacological Society,” said Liz Ferguson, SVP, Research Publishing at Wiley. “Together, we are advancing the BPS portfolio, collectively focusing on issues of current importance (such as diversity and inclusion, and research reproducibility and transparency), while developing new features technologies to make the publication experience even faster and more efficient for researchers advancing drug discovery.”
As part of this renewed partnership between BPS and Wiley, BJP and BJCP will continue to focus on accelerating their transition to open access and maintaining their excellent reputation for high quality and timely research in the field of pharmacology.
About the British Pharmacological Society
With over 4,500 members from more than 60 countries around the world, the British Pharmacological Society (BPS) is a collaborative global community at the heart of pharmacology. It was founded in 1931 and today is at the forefront of research and application of pharmacology worldwide. Guided by the mission to promote and advance all disciplines of pharmacology in the discovery, development and use of medicines, the Society’s vision is a world in which pharmacology and therapeutics stimulate and support advances in science, medicine and health care, for the benefit of all in Society. Besides the British Journal of Pharmacology and the British Journal of Clinical PharmacologyBPS publishes Pharmacology issues, the company’s digital magazine and, in partnership with Wiley and the American Society for Pharmacology and Experimental Therapeutics (ASPET), Research and perspectives in pharmacology, a peer-reviewed open access journal.
Wiley (NYSE: JWA) is a global leader in research and education, unlocking human potential by enabling discovery, fueling education and shaping the workforce. For more than 200 years, Wiley has powered the global knowledge ecosystem. Today, our high-impact content, platforms and services help researchers, learners, institutions and businesses achieve their goals in an ever-changing world. Visit us at Wiley.comLike us on Facebookand follow us on Twitter and LinkedIn.
Dawn Peters, Wiley
Billy Nichols, BPS
Warning: AAAS and EurekAlert! are not responsible for the accuracy of press releases posted on EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.